Vaxcyte, Inc.
NASDAQ:PCVX
34.8 (USD) • At close June 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 14.446 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 4.503 | 3.478 | 3.091 | 2.948 | 2.48 | 2.401 | 2.342 | 2.3 | 2.354 | 2.164 | 2.369 | 1.206 | 0.846 | 0.868 | 0.527 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -4.503 | -3.478 | -3.091 | 11.498 | -2.48 | -2.401 | -2.342 | -2.3 | -2.354 | -2.164 | -2.369 | -1.206 | -0.846 | -0.868 | -0.527 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0.796 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 148.134 | 133.614 | 116.936 | 131.507 | 94.587 | 104.15 | 97.421 | 72.691 | 58.08 | 51.626 | 47.679 | 38.469 | 31.678 | 23.074 | 20.428 | 17.651 | 17.258 | 14.661 | 16.41 | 18.178 | 24.315 | 13.382 | 9.63 | 9.968 | 12.628 |
| General & Administrative Expenses
| 32.659 | 28.555 | 22.988 | 21.474 | 19.885 | 17.526 | 15.605 | 14.456 | 13.112 | 11.952 | 10.898 | 9.417 | 7.543 | 6.772 | 6.523 | 6.079 | 5.885 | 4.792 | 4.898 | 3.046 | 3.281 | 2.457 | 2.51 | 2.264 | 1.316 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -3.478 | 0 | -2.948 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 32.659 | 28.555 | 22.988 | 17.996 | 19.885 | 14.578 | 15.605 | 14.456 | 13.112 | 11.952 | 10.898 | 9.417 | 7.543 | 6.772 | 6.523 | 6.079 | 5.885 | 4.792 | 4.898 | 3.046 | 3.281 | 2.457 | 2.51 | 2.264 | 1.316 |
| Other Expenses
| 0 | 0 | 0 | -0.394 | 0 | 75.654 | 0 | 0 | -0.654 | -0.925 | -0.157 | -0.69 | -0.16 | -0.908 | -0.299 | -0.378 | 0 | 0 | 0 | 0 | 0 | 0.665 | 0.844 | 1.45 | 0.226 |
| Operating Expenses
| 180.793 | 162.169 | 139.924 | 149.503 | 114.346 | 118.728 | 113.026 | 84.683 | 70.538 | 62.653 | 58.42 | 47.196 | 39.061 | 28.938 | 26.652 | 23.352 | 23.143 | 19.127 | 20.521 | 20.188 | 27.267 | 15.656 | 12.086 | 12.232 | 13.944 |
| Operating Income
| -180.793 | -162.169 | -139.924 | -152.981 | -114.472 | -121.676 | -113.026 | -87.147 | -71.192 | -86.573 | -58.577 | -47.886 | -39.221 | -29.846 | -26.951 | -23.73 | -23.143 | -19.453 | -21.308 | -21.224 | -27.596 | -15.839 | -12.14 | -12.232 | -13.944 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | -8.423 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 40.075 | 25.089 | 36.8 | 24.278 | 19.452 | 15.875 | 20.362 | 18.808 | 10.73 | 8.523 | 0.66 | -0.646 | 0.235 | 1.283 | 0.336 | 0.051 | 1.923 | -1.284 | 0.29 | 0.904 | 0.454 | 1.218 | 0.823 | 1.567 | 0.273 |
| Income Before Tax
| -140.718 | -137.08 | -103.124 | -128.703 | -95.02 | -180.801 | -92.664 | -68.339 | -60.462 | -78.05 | -57.917 | -48.532 | -38.986 | -28.563 | -26.615 | -23.679 | -21.22 | -20.737 | -21.018 | -20.32 | -27.142 | -14.621 | -11.317 | -10.665 | -13.671 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | -12.516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | -19.326 | 14.581 | -2.48 | 2.279 | -12.101 | 15.397 | -0.66 | 0.646 | -0.235 | 0 | 0.01 | 0.007 | 0 | -0.332 | -0.334 | 0 | 0.007 | 0.672 | 0.853 | 1.461 | 0.239 |
| Net Income
| -140.718 | -137.08 | -103.124 | -128.703 | -95.02 | -180.801 | -92.664 | -68.339 | -48.361 | -93.447 | -57.257 | -49.178 | -38.751 | -28.563 | -26.615 | -23.679 | -21.22 | -20.737 | -21.018 | -20.32 | -27.142 | -14.621 | -11.317 | -10.665 | -13.671 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | -12.516 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.04 | -1.12 | -0.83 | -1.1 | -0.85 | -1.76 | -0.91 | -0.7 | -0.56 | -1.18 | -0.92 | -0.81 | -0.68 | -0.54 | -0.51 | -0.46 | -0.41 | -0.41 | -1.02 | -1.72 | -6.7 | -3.69 | -2.93 | -2.9 | -3.72 |
| EPS Diluted
| -1.04 | -1.12 | -0.83 | -1.1 | -0.85 | -1.76 | -0.91 | -0.7 | -0.56 | -1.18 | -0.92 | -0.81 | -0.67 | -0.54 | -0.51 | -0.46 | -0.41 | -0.41 | -1.02 | -1.72 | -6.7 | -3.69 | -2.93 | -2.9 | -3.72 |
| EBITDA
| -175.919 | -52.577 | -139.924 | -152.981 | -113.473 | -177.853 | -90.184 | -87.147 | -70.48 | -75.706 | -55.563 | -47.886 | -36.617 | -27.357 | -25.769 | -22.811 | -22.616 | -20.405 | -20.718 | -19.92 | -26.751 | -14.282 | -11.008 | -10.354 | -13.364 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | -12.312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |